Rhodotorula mucilaginosa catheter-related fungaemia in a patient with multiple myeloma.
To date, there have been several case reports of Rhodotorula infection in haematological patients, but none affecting patients with multiple myeloma (MM). We describe a 54-year-old man with MM receiving prophylaxis with fluconazole who was using a subclavian Port-A-Cath and presented two episodes of fungaemia caused by Rhodotorula mucilaginosa. The first episode was resolved with oral itraconazole and neutropenia recovery. During the second episode, caspofungin was administered without success; however, liposomal amphotericin B and catheter withdrawal resolved the fungaemia. As far as we know, this is the first case reported of R. mucilaginosa fungaemia in a patient with MM.
García-Suárez
J
J
Gómez-Herruz
P
P
Cuadros
J A
JA
Guillén
H
H
Burgaleta
C
C
D000666:Amphotericin B / Q000008:administration & dosage; D000935:Antifungal Agents / Q000008:administration & dosage; D000077336:Caspofungin; D055499:Catheter-Related Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D054714:Echinocandins / Q000008:administration & dosage; D016469:Fungemia / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage; D055666:Lipopeptides; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications*; D012248:Rhodotorula / Q000302:isolation & purification*; D016896:Treatment Outcome
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; C068538:liposomal amphotericin B; D017964:Itraconazole; D000666:Amphotericin B; D000077336:Caspofungin